2016
DOI: 10.1161/strokeaha.116.012238
|View full text |Cite
|
Sign up to set email alerts
|

Efficacy of Alteplase in a Mouse Model of Acute Ischemic Stroke

Abstract: Background and purpose The debate over the fact that experimental drugs proposed for the treatment of stroke fail in the translation to the clinical situation, has attracted considerable attention in the literature. In this context, we present a retrospective pooled analysis of a large dataset from pre-clinical studies, in order to examine the effects of early versus late administration of intravenous recombinant tissue type plasminogen activator (rt-PA). Methods We collected data from 26 individual studies … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

1
48
0

Year Published

2018
2018
2021
2021

Publication Types

Select...
8
1

Relationship

5
4

Authors

Journals

citations
Cited by 36 publications
(49 citation statements)
references
References 34 publications
1
48
0
Order By: Relevance
“…Based on this study, many preclinical studies have moved on using a dosage tenfold stronger than what is used in the clinic. The higher dosage of 10 mg/kg is used in the thromboembolic stroke model in mice and has shown similar results that are seen in the clinic 22,23,25 . Studies have also produced irregularities in the efficacy of rt-PA when comparing different dosages in in vivo models 49,50 .…”
Section: Discussionmentioning
confidence: 67%
See 1 more Smart Citation
“…Based on this study, many preclinical studies have moved on using a dosage tenfold stronger than what is used in the clinic. The higher dosage of 10 mg/kg is used in the thromboembolic stroke model in mice and has shown similar results that are seen in the clinic 22,23,25 . Studies have also produced irregularities in the efficacy of rt-PA when comparing different dosages in in vivo models 49,50 .…”
Section: Discussionmentioning
confidence: 67%
“…While previous embolic models have shown variability in clot placements, the clot formed through Orset's model does not move and remains in its original location, generating high reproducibility and low mortality. The model also mimics human ischemic stroke closely by its replication of the thrombi/emboli that gives rise to the blood vessel occlusion in humans; its close clinical resemblance is one of the reasons the model is used by several research groups today [22][23][24][25][26] . With this model's advantages, translation of the model from one species to another would increase the research possibilities by utilizing the benefits from the different species.…”
mentioning
confidence: 99%
“…In this study, the skull was kept intact and image quality was degraded but still enabled quality imaging of cerebral perfusion. Our present work demonstrates in an intact skull setup with a clinically relevant model of Middle Cerebral Artery (MCA) occlusion 23 - 25 that ultrafast Doppler and ULM can provide characterization of cerebral perfusion during an ischemic episode and follow-up in mice. The potential of ULM for transcranial imaging in human patients might allow the imaging of cerebral perfusion very early after stroke onset and possible improvement in medical care.…”
Section: Introductionmentioning
confidence: 92%
“…However, the mechanisms mediating this aggravation are not well understood. Our previous results on the impact of alcohol consumption on ischemic stroke, obtained in a clinically relevant thromboembolic model of stroke (9,10), have shown that the aggravating effect of excessive drinking is not due to alcohol-induced changes in hemodynamic Alcohol abuse is a major public health problem worldwide, causing a wide range of preventable morbidity and mortality. In this translational study, we show that heavy drinking (HD) (≥6 standard drinks/day) is independently associated with a worse outcome for ischemic stroke patients.…”
Section: Introductionmentioning
confidence: 99%